Yhdysvallat - englanti - NLM (National Library of Medicine)

bristol-myers squibb pharma company - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8) - efavirenz 50 mg - sustiva® (efavirenz) in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg. - sustiva is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (eg, stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of this product. - coadministration of efavirenz with elbasvir and grazoprevir is contraindicated [see warnings and precautions (5.1) and drug interactions (7.1) ]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to sustiva during pregnancy. physicians are encouraged to register patients by calling the antiretroviral pregnancy registry at 1-800-258-4263. there are retrospective case reports of neural tube defects in infants whose mothers were exposed to efavirenz-containing regimens in the fi

Yhdysvallat - englanti - NLM (National Library of Medicine)

physicians total care, inc. - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8) - efavirenz 600 mg - sustiva® (efavirenz) in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection. this indication is based on two clinical trials of at least one year duration that demonstrated prolonged suppression of hiv rna [see clinical studies (14) ]. sustiva is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (eg, stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of this product. for some drugs, competition for cyp3a by efavirenz could result in inhibition of their metabolism and create the potential for serious and/or life-threatening adverse reactions (eg, cardiac arrhythmias, prolonged sedation, or respiratory depression). drugs that are contraindicated with sustiva are listed in table 2. pregnancy category d: see warnings and precautions (5.6) . antiretroviral pregnancy registry: to monitor fetal outcomes of pregnant women exposed to sust

Yhdysvallat - englanti - NLM (National Library of Medicine)

mylan specialty l.p. - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8), lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95), tenofovir disoproxil fumarate (unii: ott9j7900i) (tenofovir anhydrous - unii:w4hfe001u5) - efavirenz 400 mg - symfi lo® (efavirenz, lamivudine and tenofovir disoproxil fumarate) is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adult and pediatric patients weighing at least 35 kg. symfi lo is contraindicated: there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to symfi lo during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. there are retrospective case reports of neural tube defects in infants whose mothers were exposed to efv-containing regimens in the first trimester of pregnancy. although a causal relationship has not been established between exposure to efv in the first trimester and neural tube defects, similar malformations have been observed in studies conducted in monkeys at doses similar to the human dose. in addition, fetal and embryonic toxicities occurred in rats, at a dose ten times less than the human exposur

Yhdysvallat - englanti - NLM (National Library of Medicine)

mylan specialty l.p. - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8), lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95), tenofovir disoproxil fumarate (unii: ott9j7900i) (tenofovir anhydrous - unii:w4hfe001u5) - efavirenz 600 mg - symfi® (efavirenz, lamivudine and tenofovir disoproxil fumarate) is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adult and pediatric patients weighing at least 40 kg. symfi is contraindicated: there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to symfi during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. there are retrospective case reports of neural tube defects in infants whose mothers were exposed to efv-containing regimens in the first trimester of pregnancy. although a causal relationship has not been established between exposure to efv in the first trimester and neural tube defects, similar malformations have been observed in studies conducted in monkeys at doses similar to the human dose. in addition, fetal and embryonic toxicities occurred in rats, at a dose ten times less than the human exposure at recom

Kenia - englanti - Pharmacy and Poisons Board

macleods pharmaceuticals limited atlanta arcade church road andheri-kurla road - efavirenz 600 mg emtricitabine 200 mg & tenofovir… - film-coated tablet - each film coated tablet contains efavirenz usp… - antivirals for systemic use: combinations of

Malta - englanti - Medicines Authority

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - tenofovir disoproxil, efavirenz, emtricitabine - film-coated tablet - tenofovir disoproxil 245 mg efavirenz 600 mg emtricitabine 200 mg - antivirals for systemic use

Israel - englanti - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - efavirenz - film coated tablets - efavirenz 600 mg - efavirenz - efavirenz - stocrin in combination with other antiretroviral agents, is indicated for the treatment of hiv-1-infection .

Australia - englanti - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - efavirenz,emtricitabine,tenofovir disoproxil fumarate -

Australia - englanti - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - efavirenz, quantity: 200 mg - tablet, film coated - excipient ingredients: carnauba wax; hyprolose; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; sodium lauryl sulfate; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - stocrin is indicated for use in combination with other antiviral agents for the treatment of hiv-1 infection in adults and children (see clinical trials; use in children).

Malta - englanti - Medicines Authority

labomed ltd delf building,sliema road, gzira gzr1637, malta - efavirenz - film-coated tablet - efavirenz 600 mg - antivirals for systemic use